Boehringer Ingelheim Pharma GmbH & Co. KG

Industry / private company


Location: Ingelheim am Rhein, Germany (DE) DE

ISNI: 0000000121717500

ROR: https://ror.org/00q32j219

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor (2018) Saleh N, Hucke O, Kramer G, Schmidt E, Montel F, Lipinski R, Ferger B, et al. Journal article Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease (2018) Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, et al. Journal article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions (2018) Stopfer P, Giessmann T, Hohl K, Hutzel S, Schmidt S, Gansser D, Ishiguro N, et al. Journal article Biomarkers for In Vivo Assessment of Transporter Function (2018) Mueller F, Sharma A, König J, Fromm M Journal article Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin (2018) Luippold G, Mark M, Klein T, Amann KU, Daniel C Journal article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article Early diagnosis of acute coronary syndrome (2017) Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, et al. Journal article Nintedanib macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis (2017) Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, Harre U, et al. Journal article